HIT: Anti-Platelet Factor 4-Heparin (PF4-H) Assay Validation and Comparison Study

American Society for Clinical Laboratory Science

doi 10.29074/ascls.119.001966

Full Text

Abstract

Available in

Date

October 14, 2019

Authors

Publisher

American Society for Clinical Laboratory Science

Related search

A Novel PF4-Dependent Platelet Activation Assay Identifies Patients Likely to Have Heparin-Induced Thrombocytopenia/Thrombosis

Cardiovascular Medicine

Intensive Care Medicine

Respiratory Medicine

English

A Platelet Factor 4-Dependent Platelet Activation Assay Facilitates Early Detection of Pathogenic Heparin-Induced Thrombocytopenia Antibodies

Cardiovascular Medicine

Intensive Care Medicine

Respiratory Medicine

English

Heparin Neutralization by Platelet-Rich Thrombi. Role of Platelet Factor 4

Cardiovascular Medicine

English

The Appropriateness of Testing Platelet Factor 4/Heparin Antibody in Patients Suspected of Heparin-Induced Thrombocytopenia

English

Optimization of a Murine Immunization Model for Study of PF4/heparin Antibodies

Journal of Thrombosis and Haemostasis

English

Heparin-Induced Thrombocytopenia (HIT)

English

Characterization of PF4-Heparin Complexes by Photon Correlation Spectroscopy and Zeta Potential

Clinical and Applied Thrombosis/Hemostasis

English

Heparin-Dependent Platelet Factor 4 Antibodies and the Impact of Renal Function on Clinical Outcomes: A Retrospective Study in Hospitalized Patients

Journal of Thrombosis and Thrombolysis

Cardiovascular Medicine

English

Close Approximation of Two Platelet Factor 4 Tetramers by Charge Neutralization Forms the Antigens Recognized by HIT Antibodies

Arteriosclerosis, Thrombosis, and Vascular Biology

Cardiovascular Medicine

English